Complemented by survival analysis, identifying AKT2 and PRKCA as prognostic markers significantly correlated with lung cancer patient overall survival, we thereby prioritized these five genes as potential therapeutic targets for peiminine. This evidence concerns the gene AKT2 and lung cancer.